The rising interest in GLP-1 agonists for metabolic health has sparked a debate about delivery routes : skin-applied devices versus capsules. Traditionally , GLP-1 treatments were solely available in oral https://keiranoftf330245.tblogz.com/glp-1-transdermal-delivery-systems-vs-pills-which-best-for-the-patient-54142038